Drug General Information (ID: D0555)
  Drug Name
Elagolix
  Drug Type Small molecule
  Drug Synonymous
Elagolix; 834153-87-6; UNII-5B2546MB5Z; NBI-56418; 5B2546MB5Z; NBI56418; NBI 56418; Elagolix [USAN:INN]; Orilissa; ELA gOLIX; Elagolix (USAN/INN); SCHEMBL1642523; GTPL8362; CHEMBL1208155; DTXSID40232348; ABT-620; 4-[[(1R)-2-[5-(2-fluoro-3-methoxyphenyl)-3-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-4-methyl-2,6-dioxopyrimidin-1-yl]-1-phenylethyl]amino]butanoic acid; EX-A1765; BCP08827; ZINC49888891; CS-5329; SB16700; DB11979; compound 10b [PMID 19006286]; HY-14789; AN-27202; D09335; Z-3253; 153E876; Butanoic acid, 4-(((1R)-2-(5-(2-flu
    Click to Show/Hide
  Disease Class 2E86: Uterine fibroid
  Therapeutic Class Gonadotropin-Releasing Hormone Antagonists
  Structure Could Not Find 2D Structure
3D Structure 2D Structure
  Formula C32H30F5N3O5
  InChI 1S/C32H30F5N3O5/c1-19-28(21-11-6-14-26(45-2)29(21)34)30(43)40(18-25(20-9-4-3-5-10-20)38-16-8-15-27(41)42)31(44)39(19)17-22-23(32(35,36)37)12-7-13-24(22)33/h3-7,9-14,25,38H,8,15-18H2,1-2H3,(H,41,42)/t25-/m0/s1
  InChIKey HEAUOKZIVMZVQL-VWLOTQADSA-N
  Canonical SMILES CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F
  External Link
Pubchem ID 11250647
CAS Number 834153-87-6
TTD ID D0UI3T

Drug-Drug Interaction Network
  Sunburst Graph
AM002  Affected cellular transport
AM004  Affected intra/extra-hepatic metabolism
AM006  Pharmacodynamic additive effects
AM007  Pharmacodynamic antagonistic effects
BM010  Transporter inhibition
BM011  Transporter induction
BM017  CYP450 enzyme inhibition
BM022  CYP450 enzyme induction
BM055  Increased risk of hepatotoxicity
BM076  Increased risk of prolong QT interval
BM107  Attenuated pharmacological effects (Unspecific)
  Relation Graph
 Full list of drugs interacting with Elagolix
      Affected cellular transport
   Transporter inhibition Drug Num:  17
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0402
 
Cyclosporine
 
C62H111N11O12
 
5284373 
Major    Inter Info   
[1]
D0551
 
Edoxaban
 
C24H30ClN7O4S
 
10280735 
Major    Inter Info   
[6], [14], [15], [16]
D0171
 
Berotralstat
 
C30H26F4N6O
 
137528262 
Major    Inter Info   
[17], [18], [19]
D0715
 
Gemfibrozil
 
C15H22O3
 
3463 
Major    Inter Info   
[1]
D1400
 
Rifampicin
 
C43H58N4O12
 
135398735 
Major    Inter Info   
[1]
D0182
 
Binimetinib
 
C17H15BrF2N4O3
 
10288191 
Moderate    Inter Info   
[5], [6], [64]
D0429
 
Daunorubicin
 
C27H29NO10
 
30323 
Moderate    Inter Info   
[98], [99], [100], [101]
D0430
 
Daunorubicin (liposomal)
 
C27H29NO10
 
30323 
Moderate    Inter Info   
[98], [100], [101]
D0176
 
Betrixaban
 
C23H22ClN5O3
 
10275777 
Moderate    Inter Info   
[156]
D0720
 
Gilteritinib
 
C29H44N8O3
 
49803313 
Moderate    Inter Info   
[6], [166]
D0899
 
Lefamulin
 
C28H45NO5S
 
25185057 
Moderate    Inter Info   
[169]
D0963
 
Lusutrombopag
 
C29H32Cl2N2O5S
 
49843517 
Moderate    Inter Info   
[161]
D0788
 
Idarubicin
 
C26H27NO9
 
42890 
Moderate    Inter Info   
[98], [99], [100], [101]
D1101
 
Naldemedine
 
C32H34N4O6
 
54732242 
Moderate    Inter Info   
[6], [242]
D1532
 
Talazoparib
 
C19H14F2N6O
 
135565082 
Moderate    Inter Info   
[296]
D0658
 
Fidaxomicin
 
C52H74Cl2O18
 
10034073 
Minor    Inter Info   
[5], [6], [323]
D0797
 
Indacaterol
 
C24H28N2O3
 
6918554 
Minor    Inter Info   
[325]
      Affected intra/extra-hepatic metabolism
   CYP450 enzyme inhibition Drug Num:  35
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0116
 
Atazanavir
 
C38H52N6O7
 
148192 
Major    Inter Info   
[1]
D0192
 
Boceprevir
 
C27H45N5O5
 
10324367 
Major    Inter Info   
[1], [2], [3]
D0302
 
Ceritinib
 
C28H36ClN5O3S
 
57379345 
Major    Inter Info   
[1]
D0349
 
Clarithromycin
 
C38H69NO13
 
84029 
Major    Inter Info   
[1]
D0375
 
Cobicistat
 
C40H53N7O5S2
 
25151504 
Major    Inter Info   
[1]
D0386
 
Conivaptan
 
C32H26N4O2
 
151171 
Major    Inter Info   
[1]
D0439
 
Delavirdine
 
C22H28N6O3S
 
5625 
Major    Inter Info   
[1], [2], [3]
D1653
 
Troleandomycin
 
C41H67NO15
 
202225 
Major    Inter Info   
[1], [2], [3]
D0789
 
Idelalisib
 
C22H18FN7O
 
11625818 
Major    Inter Info   
[1]
D0799
 
Indinavir
 
C36H47N5O4
 
5362440 
Major    Inter Info   
[1]
D0867
 
Itraconazole
 
C35H38Cl2N8O4
 
55283 
Major    Inter Info   
[1]
D0880
 
Ketoconazole
 
C26H28Cl2N4O4
 
456201 
Major    Inter Info   
[1]
D1117
 
Nefazodone
 
C25H32ClN5O2
 
4449 
Major    Inter Info   
[1]
D1119
 
Nelfinavir
 
C32H45N3O4S
 
64143 
Major    Inter Info   
[1]
D1315
 
Posaconazole
 
C37H42F2N8O4
 
468595 
Major    Inter Info   
[1]
D1388
 
Relugolix
 
C29H27F2N7O5S
 
10348973 
Major    Inter Info   
[43]
D1415
 
Ritonavir
 
C37H48N6O5S2
 
392622 
Major    Inter Info   
[1]
D1444
 
Saquinavir
 
C38H50N6O5
 
441243 
Major    Inter Info   
[1]
D1541
 
Telaprevir
 
C36H53N7O6
 
3010818 
Major    Inter Info   
[1], [2], [3]
D1544
 
Telithromycin
 
C43H65N5O10
 
3002190 
Major    Inter Info   
[1], [2], [3]
D1706
 
Voriconazole
 
C16H14F3N5O
 
71616 
Major    Inter Info   
[1]
D0007
 
Abiraterone
 
C24H31NO
 
132971 
Moderate    Inter Info   
[1]
D0100
 
Aprepitant
 
C23H21F7N4O3
 
135413536 
Moderate    Inter Info   
[1]
D0180
 
Bicalutamide
 
C18H14F4N2O4S
 
2375 
Moderate    Inter Info   
[1]
D0313
 
Chloramphenicol
 
C11H12Cl2N2O5
 
5959 
Moderate    Inter Info   
[1]
D0337
 
Cimetidine
 
C10H16N6S
 
2756 
Moderate    Inter Info   
[1]
D0341
 
Ciprofloxacin
 
C17H18FN3O3
 
2764 
Moderate    Inter Info   
[1]
D0367
 
Clotrimazole
 
C22H17ClN2
 
2812 
Moderate    Inter Info   
[1]
D0413
 
Dalfopristin
 
C34H50N4O9S
 
6323289 
Moderate    Inter Info   
[1]
D0416
 
Danazol
 
C22H27NO2
 
28417 
Moderate    Inter Info   
[1]
D0497
 
Diltiazem
 
C22H26N2O4S
 
39186 
Moderate    Inter Info   
[1]
D0696
 
Fosnetupitant
 
C31H35F6N4O5P
 
71544786 
Moderate    Inter Info   
[1]
D0693
 
Fosaprepitant
 
C23H22F7N4O6P
 
135413538 
Moderate    Inter Info   
[1]
D1063
 
Mifepristone
 
C29H35NO2
 
55245 
Moderate    Inter Info   
[1]
D1127
 
Netupitant
 
C30H32F6N4O
 
6451149 
Moderate    Inter Info   
[1]
   CYP450 enzyme induction Drug Num:  198
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0226
 
Butorphanol
 
C21H29NO2
 
5361092 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0161
 
Benzhydrocodone
 
C25H25NO4
 
49836084 
Major    Inter Info   
[10], [11], [12]
D1169
 
Oliceridine
 
C22H30N2O2S
 
66553195 
Major    Inter Info   
[10], [11], [12]
D1538
 
Tazemetostat
 
C34H44N4O4
 
66558664 
Major    Inter Info   
[21], [22]
D0646
 
Fentanyl
 
C22H28N2O
 
3345 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0772
 
Hydrocodone
 
C18H21NO3
 
5284569 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0909
 
Levacetylmethadol
 
C23H31NO2
 
15130 
Major    Inter Info   
[25], [26]
D0946
 
Lonafarnib
 
C27H31Br2ClN4O2
 
148195 
Major    Inter Info   
[25], [28]
D0959
 
Lumateperone
 
C24H28FN3O
 
21302490 
Major    Inter Info   
[29]
D1017
 
Methadone
 
C21H27NO
 
4095 
Major    Inter Info   
[30], [31], [32], [33], [34], [35], [36], [37], [38], [39], [40], [41]
D1203
 
Oxycodone
 
C18H21NO4
 
5284603 
Major    Inter Info   
[4], [5], [6], [7], [8], [9], [10], [11], [12], [13]
D0008
 
Acalabrutinib
 
C26H23N7O2
 
71226662 
Moderate    Inter Info   
[44]
D0035
 
Alfentanil
 
C21H32N6O3
 
51263 
Moderate    Inter Info   
[45], [46], [47], [48]
D0061
 
Aminoglutethimide
 
C13H16N2O2
 
2145 
Moderate    Inter Info   
[1]
D0071
 
Amobarbital
 
C11H18N2O3
 
2164 
Moderate    Inter Info   
[1]
D0080
 
Amprenavir
 
C25H35N3O6S
 
65016 
Moderate    Inter Info   
[49], [50], [51]
D0095
 
Apalutamide
 
C21H15F4N5O2S
 
24872560 
Moderate    Inter Info   
[1]
D0099
 
Apremilast
 
C22H24N2O7S
 
11561674 
Moderate    Inter Info   
[52]
D0105
 
Aripiprazole
 
C23H27Cl2N3O2
 
60795 
Moderate    Inter Info   
[53]
D0106
 
Armodafinil
 
C15H15NO2S
 
9690109 
Moderate    Inter Info   
[1]
D0108
 
Artemether
 
C16H26O5
 
68911 
Moderate    Inter Info   
[5], [6], [54]
D0120
 
Atorvastatin
 
C33H35FN2O5
 
60823 
Moderate    Inter Info   
[55], [56], [57], [58], [59]
D0128
 
Avanafil
 
C23H26ClN7O3
 
9869929 
Moderate    Inter Info   
[60]
D0133
 
Axitinib
 
C22H18N4OS
 
6450551 
Moderate    Inter Info   
[61], [62]
D0149
 
Bedaquiline
 
C32H31BrN2O2
 
5388906 
Moderate    Inter Info   
[63]
D0178
 
Bexarotene
 
C24H28O2
 
82146 
Moderate    Inter Info   
[1]
D0194
 
Bosentan
 
C27H29N5O6S
 
104865 
Moderate    Inter Info   
[1]
D0219
 
Buprenorphine
 
C29H41NO4
 
644073 
Moderate    Inter Info   
[66]
D0222
 
Buspirone
 
C21H31N5O2
 
2477 
Moderate    Inter Info   
[67], [68], [69]
D0224
 
Butabarbital
 
C10H16N2O3
 
2479 
Moderate    Inter Info   
[1]
D0225
 
Butalbital
 
C11H16N2O3
 
2481 
Moderate    Inter Info   
[1]
D0227
 
Cabazitaxel
 
C45H57NO14
 
9854073 
Moderate    Inter Info   
[70]
D0230
 
Cabozantinib
 
C28H24FN3O5
 
25102847 
Moderate    Inter Info   
[71], [72]
D0251
 
Capmatinib
 
C23H17FN6O
 
25145656 
Moderate    Inter Info   
[74]
D0255
 
Carbamazepine
 
C15H12N2O
 
2554 
Moderate    Inter Info   
[1]
D0268
 
Caspofungin
 
C52H88N10O15
 
2826718 
Moderate    Inter Info   
[75]
D0300
 
Cenobamate
 
C10H10ClN5O2
 
11962412 
Moderate    Inter Info   
[1]
D0376
 
Cobimetinib
 
C21H21F3IN3O2
 
16222096 
Moderate    Inter Info   
[77]
D0393
 
Crizotinib
 
C21H22Cl2FN5O
 
11626560 
Moderate    Inter Info   
[80], [6], [81]
D0406
 
Dabrafenib
 
C23H20F3N5O2S2
 
44462760 
Moderate    Inter Info   
[6], [82]
D0424
 
Darifenacin
 
C28H30N2O2
 
444031 
Moderate    Inter Info   
[83]
D0426
 
Darunavir
 
C27H37N3O7S
 
213039 
Moderate    Inter Info   
[84], [85], [86], [4], [87], [88], [89], [90], [91], [92], [93], [94], [95], [49], [96], [50], [51]
D0428
 
Dasatinib
 
C22H26ClN7O2S
 
3062316 
Moderate    Inter Info   
[5], [6], [97]
D0432
 
Deferasirox
 
C21H15N3O4
 
214348 
Moderate    Inter Info   
[1]
D0453
 
Dexamethasone
 
C22H29FO5
 
5743 
Moderate    Inter Info   
[1]
D0494
 
Dihydroergotamine
 
C33H37N5O5
 
10531 
Moderate    Inter Info   
[5], [6], [102]
D0516
 
Donepezil
 
C24H29NO3
 
3152 
Moderate    Inter Info   
[103]
D0534
 
Dronedarone
 
C31H44N2O5S
 
208898 
Moderate    Inter Info   
[104]
D0536
 
Drospirenone
 
C24H30O3
 
68873 
Moderate    Inter Info   
[105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151]
D0543
 
Duvelisib
 
C22H17ClN6O
 
50905713 
Moderate    Inter Info   
[152]
D0554
 
Efavirenz
 
C14H9ClF3NO2
 
64139 
Moderate    Inter Info   
[1]
D0006
 
Abemaciclib
 
C27H32F2N8
 
46220502 
Moderate    Inter Info   
[153]
D0044
 
Alpelisib
 
C19H22F3N5O2S
 
56649450 
Moderate    Inter Info   
[154]
D0129
 
Avapritinib
 
C26H27FN10
 
118023034 
Moderate    Inter Info   
[6], [155]
D0204
 
Brigatinib
 
C29H39ClN7O2P
 
68165256 
Moderate    Inter Info   
[5], [6], [157]
D0389
 
Copanlisib
 
C23H28N8O4
 
135565596 
Moderate    Inter Info   
[158]
D0425
 
Darolutamide
 
C19H19ClN6O2
 
67171867 
Moderate    Inter Info   
[159]
D0518
 
Doravirine
 
C17H11ClF3N5O3
 
58460047 
Moderate    Inter Info   
[160], [161]
D0577
 
Entrectinib
 
C31H34F2N6O2
 
25141092 
Moderate    Inter Info   
[6], [162]
D0601
 
Eslicarbazepine
 
C15H14N2O2
 
9881504 
Moderate    Inter Info   
[1]
D0699
 
Fostamatinib
 
C23H26FN6O9P
 
11671467 
Moderate    Inter Info   
[163], [164], [165]
D0726
 
Glecaprevir
 
C38H46F4N6O9S
 
66828839 
Moderate    Inter Info   
[167]
D0872
 
Ivosidenib
 
C28H22ClF3N6O3
 
71657455 
Moderate    Inter Info   
[1]
D0896
 
Larotrectinib
 
C21H22F2N6O2
 
46188928 
Moderate    Inter Info   
[5], [6], [168]
D0953
 
Lorlatinib
 
C21H19FN6O2
 
71731823 
Moderate    Inter Info   
[1]
D0965
 
Macimorelin
 
C26H30N6O3
 
9804938 
Moderate    Inter Info   
[170]
D1242
 
Pemigatinib
 
C24H27F2N5O4
 
86705695 
Moderate    Inter Info   
[6], [171]
D1409
 
Ripretinib
 
C24H21BrFN5O2
 
71584930 
Moderate    Inter Info   
[5], [175]
D1459
 
Selpercatinib
 
C29H31N7O3
 
134436906 
Moderate    Inter Info   
[163], [176]
D1546
 
Telotristat ethyl
 
C27H26ClF3N6O3
 
25181577 
Moderate    Inter Info   
[1]
D1663
 
Ubrogepant
 
C29H26F3N5O3
 
68748835 
Moderate    Inter Info   
[177]
D1718
 
Zanubrutinib
 
C27H29N5O3
 
135565884 
Moderate    Inter Info   
[178]
D0556
 
Elbasvir
 
C49H55N9O7
 
71661251 
Moderate    Inter Info   
[179]
D0559
 
Eliglustat
 
C23H36N2O4
 
23652731 
Moderate    Inter Info   
[180]
D0563
 
Elvitegravir
 
C23H23ClFNO5
 
5277135 
Moderate    Inter Info   
[5], [6], [181]
D0569
 
Encorafenib
 
C22H27ClFN7O4S
 
50922675 
Moderate    Inter Info   
[182]
D0578
 
Enzalutamide
 
C21H16F4N4O2S
 
15951529 
Moderate    Inter Info   
[1]
D0592
 
Ergometrine
 
C19H23N3O2
 
443884 
Moderate    Inter Info   
[5], [6], [102]
D0593
 
Ergotamine
 
C33H35N5O5
 
8223 
Moderate    Inter Info   
[5], [6], [102]
D0595
 
Erlotinib
 
C22H23N3O4
 
176870 
Moderate    Inter Info   
[183], [184]
D0612
 
Eszopiclone
 
C17H17ClN6O3
 
969472 
Moderate    Inter Info   
[185]
D0626
 
Etonogestrel
 
C22H28O2
 
6917715 
Moderate    Inter Info   
[105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151]
D0628
 
Etravirine
 
C20H15BrN6O
 
193962 
Moderate    Inter Info   
[186]
D0629
 
Everolimus
 
C53H83NO14
 
6442177 
Moderate    Inter Info   
[5], [6], [187]
D0630
 
Exemestane
 
C20H24O2
 
60198 
Moderate    Inter Info   
[188]
D0639
 
Felbamate
 
C11H14N2O4
 
3331 
Moderate    Inter Info   
[1]
D0655
 
Fesoterodine
 
C26H37NO3
 
6918558 
Moderate    Inter Info   
[189]
D0665
 
Flibanserin
 
C20H21F3N4O
 
6918248 
Moderate    Inter Info   
[190]
D0692
 
Fosamprenavir
 
C25H36N3O9PS
 
131536 
Moderate    Inter Info   
[84], [85], [86], [4], [87], [88], [89], [90], [91], [92], [93], [94], [95], [49], [96], [50], [51]
D0697
 
Fosphenytoin
 
C16H15N2O6P
 
56339 
Moderate    Inter Info   
[1]
D0713
 
Gefitinib
 
C22H24ClFN4O3
 
123631 
Moderate    Inter Info   
[183], [191]
D0725
 
Glasdegib
 
C21H22N6O
 
25166913 
Moderate    Inter Info   
[192]
D0732
 
Glycerol phenylbutyrate
 
C33H38O6
 
10482134 
Moderate    Inter Info   
[1]
D0741
 
Griseofulvin
 
C17H17ClO6
 
441140 
Moderate    Inter Info   
[1]
D0745
 
Guanfacine
 
C9H9Cl2N3O
 
3519 
Moderate    Inter Info   
[6], [193], [194]
D0785
 
Ibrutinib
 
C25H24N6O2
 
24821094 
Moderate    Inter Info   
[195]
D0793
 
Imatinib
 
C29H31N7O
 
5291 
Moderate    Inter Info   
[196], [4], [5], [6], [197], [198]
D0845
 
Irinotecan
 
C33H38N4O6
 
60838 
Moderate    Inter Info   
[203], [204], [205], [206], [207], [208], [209], [210], [211], [212], [213], [214], [215], [216], [217]
D0846
 
Irinotecan (liposomal)
 
C33H38N4O6
 
60838 
Moderate    Inter Info   
[204], [205], [210]
D0868
 
Ivabradine
 
C27H36N2O5
 
132999 
Moderate    Inter Info   
[6], [218]
D0869
 
Ivacaftor
 
C24H28N2O3
 
16220172 
Moderate    Inter Info   
[219], [220], [221], [222]
D0873
 
Ixabepilone
 
C27H42N2O5S
 
6445540 
Moderate    Inter Info   
[223]
D0874
 
Ixazomib
 
C14H19BCl2N2O4
 
25183872 
Moderate    Inter Info   
[224]
D0894
 
Lapatinib
 
C29H26ClFN4O4S
 
208908 
Moderate    Inter Info   
[5], [6], [225]
D0905
 
Lesinurad
 
C17H14BrN3O2S
 
53465279 
Moderate    Inter Info   
[1]
D0922
 
Levonorgestrel
 
C21H28O2
 
13109 
Moderate    Inter Info   
[105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151]
D0930
 
Linagliptin
 
C25H28N8O2
 
10096344 
Moderate    Inter Info   
[226]
D0961
 
Lurasidone
 
C28H36N4O2S
 
213046 
Moderate    Inter Info   
[5], [6], [227]
D0966
 
Macitentan
 
C19H20Br2N6O4S
 
16004692 
Moderate    Inter Info   
[228], [229]
D0980
 
Maraviroc
 
C29H41F2N5O
 
3002977 
Moderate    Inter Info   
[5], [230]
D0990
 
Medroxyprogesterone acetate
 
C24H34O4
 
6279 
Moderate    Inter Info   
[231], [232], [151]
D0992
 
Mefloquine
 
C17H16F6N2O
 
4046 
Moderate    Inter Info   
[233]
D0993
 
Megestrol acetate
 
C24H32O4
 
11683 
Moderate    Inter Info   
[109], [119], [144]
D1037
 
Methylergometrine
 
C20H25N3O2
 
8226 
Moderate    Inter Info   
[5], [6], [102]
D1040
 
Methylphenobarbital
 
C13H14N2O3
 
8271 
Moderate    Inter Info   
[1]
D1043
 
Methysergide
 
C21H27N3O2
 
9681 
Moderate    Inter Info   
[5], [6], [102]
D1062
 
Midostaurin
 
C35H30N4O4
 
9829523 
Moderate    Inter Info   
[235], [236]
D1075
 
Mirtazapine
 
C17H19N3
 
4205 
Moderate    Inter Info   
[237], [238], [239], [240]
D1078
 
Mitotane
 
C14H10Cl4
 
4211 
Moderate    Inter Info   
[1]
D1081
 
Modafinil
 
C15H15NO2S
 
4236 
Moderate    Inter Info   
[1]
D1087
 
Montelukast
 
C35H36ClNO3S
 
5281040 
Moderate    Inter Info   
[241]
D1099
 
Nafcillin
 
C21H22N2O5S
 
8982 
Moderate    Inter Info   
[1]
D1104
 
Naloxegol
 
C34H53NO11
 
56959087 
Moderate    Inter Info   
[243]
D1128
 
Nevirapine
 
C15H14N4O
 
4463 
Moderate    Inter Info   
[1]
D1136
 
Nilotinib
 
C28H22F3N7O
 
644241 
Moderate    Inter Info   
[245]
D1143
 
Nitisinone
 
C14H10F3NO5
 
115355 
Moderate    Inter Info   
[4], [5], [6]
D1154
 
Norethisterone
 
C20H26O2
 
6230 
Moderate    Inter Info   
[109], [119], [144]
D1157
 
Norgestrel
 
C21H28O2
 
13109 
Moderate    Inter Info   
[109], [119], [144]
D1167
 
Olaparib
 
C24H23FN4O3
 
23725625 
Moderate    Inter Info   
[5], [6], [246]
D1186
 
Oritavancin
 
C86H97Cl3N10O26
 
16136912 
Moderate    Inter Info   
[1]
D1189
 
Osilodrostat
 
C13H10FN3
 
44139752 
Moderate    Inter Info   
[163], [247], [165]
D1190
 
Osimertinib
 
C28H33N7O2
 
71496458 
Moderate    Inter Info   
[248]
D1198
 
Oxcarbazepine
 
C15H12N2O2
 
34312 
Moderate    Inter Info   
[1]
D1212
 
Paclitaxel
 
C47H51NO14
 
36314 
Moderate    Inter Info   
[249], [250], [251], [252]
D1213
 
Paclitaxel (protein-bound)
 
C47H51NO14
 
36314 
Moderate    Inter Info   
[249], [250], [251]
D1214
 
Palbociclib
 
C24H29N7O2
 
5330286 
Moderate    Inter Info   
[5], [6], [253]
D1221
 
Panobinostat
 
C21H23N3O2
 
6918837 
Moderate    Inter Info   
[254]
D1232
 
Pazopanib
 
C21H23N7O2S
 
10113978 
Moderate    Inter Info   
[255]
D1248
 
Pentobarbital
 
C11H18N2O3
 
4737 
Moderate    Inter Info   
[1]
D1253
 
Perampanel
 
C23H15N3O
 
9924495 
Moderate    Inter Info   
[6], [256]
D1265
 
Phenobarbital
 
C12H12N2O3
 
4763 
Moderate    Inter Info   
[1]
D1274
 
Phenylbutazone
 
C19H20N2O2
 
4781 
Moderate    Inter Info   
[1]
D1283
 
Phenytoin
 
C15H12N2O2
 
1775 
Moderate    Inter Info   
[1]
D1290
 
Pimavanserin
 
C25H34FN3O2
 
10071196 
Moderate    Inter Info   
[257]
D1313
 
Ponatinib
 
C29H27F3N6O
 
24826799 
Moderate    Inter Info   
[5], [6], [258]
D1330
 
Praziquantel
 
C19H24N2O2
 
4891 
Moderate    Inter Info   
[259], [5], [260], [261]
D1340
 
Primidone
 
C12H14N2O2
 
4909 
Moderate    Inter Info   
[1]
D1348
 
Progesterone
 
C21H30O2
 
5994 
Moderate    Inter Info   
[105], [106], [107], [108], [109], [110], [111], [112], [113], [114], [115], [116], [117], [118], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [129], [130], [131], [132], [133], [134], [135], [136], [137], [138], [139], [140], [141], [142], [143], [144], [145], [146], [147], [148], [149], [150], [151]
D1349
 
Progesterone (topical)
 
C21H30O2
 
5994 
Moderate    Inter Info   
[109], [119], [144]
D1368
 
Quetiapine
 
C21H25N3O2S
 
5002 
Moderate    Inter Info   
[5], [262], [263], [264], [265]
D1372
 
Quinine
 
C20H24N2O2
 
3034034 
Moderate    Inter Info   
[266], [267], [12], [268], [269], [270]
D1378
 
Ramelteon
 
C16H21NO2
 
208902 
Moderate    Inter Info   
[271]
D1392
 
Repaglinide
 
C27H36N2O4
 
65981 
Moderate    Inter Info   
[272], [273], [274]
D1398
 
Ribociclib
 
C23H30N8O
 
44631912 
Moderate    Inter Info   
[5], [6], [275]
D1399
 
Rifabutin
 
C46H62N4O11
 
135398743 
Moderate    Inter Info   
[1]
D1401
 
Rifapentine
 
C47H64N4O12
 
135403821 
Moderate    Inter Info   
[1]
D1404
 
Rilpivirine
 
C22H18N6
 
6451164 
Moderate    Inter Info   
[5], [80], [6], [276]
D1408
 
Riociguat
 
C20H19FN8O2
 
11304743 
Moderate    Inter Info   
[277]
D1423
 
Rolapitant
 
C25H26F6N2O2
 
10311306 
Moderate    Inter Info   
[278]
D1433
 
Rufinamide
 
C10H8F2N4O
 
129228 
Moderate    Inter Info   
[1]
D1434
 
Ruxolitinib
 
C17H18N6
 
25126798 
Moderate    Inter Info   
[279]
D1449
 
Saxagliptin
 
C18H25N3O2
 
11243969 
Moderate    Inter Info   
[280]
D1453
 
Secobarbital
 
C12H18N2O3
 
5193 
Moderate    Inter Info   
[1]
D1460
 
Selumetinib
 
C17H15BrClFN4O3
 
10127622 
Moderate    Inter Info   
[281]
D1465
 
Sildenafil
 
C22H30N6O4S
 
135398744 
Moderate    Inter Info   
[282], [283], [284], [285]
D1476
 
Sirolimus
 
C51H79NO13
 
5284616 
Moderate    Inter Info   
[5], [6], [286], [287]
D1491
 
Solifenacin
 
C23H26N2O2
 
154059 
Moderate    Inter Info   
[288]
D1496
 
Sonidegib
 
C26H26F3N3O3
 
24775005 
Moderate    Inter Info   
[289]
D1497
 
Sorafenib
 
C21H16ClF3N4O3
 
216239 
Moderate    Inter Info   
[290]
D1502
 
St. John's Wort
 
NA
 
NA
Moderate    Inter Info   
[1]
D1505
 
Stiripentol
 
C14H18O3
 
5311454 
Moderate    Inter Info   
[6], [197], [291]
D1518
 
Sulfinpyrazone
 
C23H20N2O3S
 
5342 
Moderate    Inter Info   
[1]
D1522
 
Sunitinib
 
C22H27FN4O2
 
5329102 
Moderate    Inter Info   
[5], [6], [292]
D1524
 
Suvorexant
 
C23H23ClN6O2
 
24965990 
Moderate    Inter Info   
[293]
D1526
 
Tacrolimus
 
C44H69NO12
 
445643 
Moderate    Inter Info   
[5], [6], [286], [287]
D1527
 
Tadalafil
 
C22H19N3O4
 
110635 
Moderate    Inter Info   
[6], [294], [295]
D1533
 
Tamoxifen
 
C26H29NO
 
2733526 
Moderate    Inter Info   
[297], [298], [299], [300]
D1536
 
Tasimelteon
 
C15H19NO2
 
10220503 
Moderate    Inter Info   
[301]
D1549
 
Temsirolimus
 
C56H87NO16
 
6918289 
Moderate    Inter Info   
[5], [6], [302]
D1579
 
Ticagrelor
 
C23H28F2N6O4S
 
9871419 
Moderate    Inter Info   
[4], [6], [303], [304], [305]
D1592
 
Tipranavir
 
C31H33F3N2O5S
 
54682461 
Moderate    Inter Info   
[84], [85], [86], [4], [87], [88], [89], [90], [91], [92], [93], [94], [95], [49], [96], [50], [51]
D1600
 
Tofacitinib
 
C16H20N6O
 
9926791 
Moderate    Inter Info   
[5], [308]
D1608
 
Tolvaptan
 
C26H25ClN2O3
 
216237 
Moderate    Inter Info   
[6], [309]
D1612
 
Toremifene
 
C26H28ClNO
 
3005573 
Moderate    Inter Info   
[310], [5], [6], [298], [311]
D1652
 
Troglitazone
 
C24H27NO5S
 
5591 
Moderate    Inter Info   
[1]
D1660
 
Tucatinib
 
C26H24N8O2
 
51039094 
Moderate    Inter Info   
[163], [313], [165]
D1687
 
Vemurafenib
 
C23H18ClF2N3O3S
 
42611257 
Moderate    Inter Info   
[1]
D1696
 
Vilazodone
 
C26H27N5O2
 
6918314 
Moderate    Inter Info   
[314]
D1708
 
Vortioxetine
 
C18H22N2S
 
9966051 
Moderate    Inter Info   
[315]
D0193
 
Bortezomib
 
C19H25BN4O4
 
387447 
Minor    Inter Info   
[6], [316], [317], [318], [319]
D0308
 
Cevimeline
 
C10H17NOS
 
83898 
Minor    Inter Info   
[320]
D0420
 
Dapsone (topical)
 
C12H12N2O2S
 
2955 
Minor    Inter Info   
[321], [219], [222]
D0515
 
Dolutegravir
 
C20H19F2N3O5
 
54726191 
Minor    Inter Info   
[322]
D0700
 
Fostemsavir
 
C25H26N7O8P
 
11319217 
Minor    Inter Info   
[163], [324], [165]
D0916
 
Levobupivacaine
 
C18H28N2O
 
92253 
Minor    Inter Info   
[25], [326]
D0927
 
Lidocaine
 
C14H22N2O
 
3676 
Minor    Inter Info   
[327], [328], [329], [330]
D1074
 
Mirabegron
 
C21H24N4O2S
 
9865528 
Minor    Inter Info   
[331]
D1726
 
Ziprasidone
 
C21H21ClN4OS
 
60854 
Minor    Inter Info   
[332], [333]
      Pharmacodynamic additive effects
   Increased risk of hepatotoxicity Drug Num:  16
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D1258
 
Pexidartinib
 
C20H15ClF3N5
 
25151352 
Major    Inter Info   
[20]
D0900
 
Leflunomide
 
C12H9F3N2O2
 
3899 
Major    Inter Info   
[4], [23], [24]
D0944
 
Lomitapide
 
C39H37F6N3O2
 
9853053 
Major    Inter Info   
[27]
D1073
 
Mipomersen
 
C230H324N67O122P19S19
 
118984467 
Major    Inter Info   
[42]
D1556
 
Teriflunomide
 
C12H9F3N2O2
 
54684141 
Major    Inter Info   
[4], [23], [24]
D0199
 
Brentuximab vedotin
 
NA
 
NA
Moderate    Inter Info   
[65]
D0248
 
Cannabidiol
 
C21H30O2
 
644019 
Moderate    Inter Info   
[6], [73]
D0357
 
Clofarabine
 
C10H11ClFN5O3
 
119182 
Moderate    Inter Info   
[76]
D1389
 
Remdesivir
 
C27H35N6O8P
 
121304016 
Moderate    Inter Info   
[5], [6], [172], [173], [174]
D0826
 
Interferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[199], [200], [201], [202]
D0827
 
Interferon beta-1b
 
NA
 
NA
Moderate    Inter Info   
[199], [200], [201], [202]
D1025
 
Methotrexate
 
C20H22N8O5
 
126941 
Moderate    Inter Info   
[6], [234]
D1106
 
Naltrexone
 
C20H23NO4
 
5360515 
Moderate    Inter Info   
[244]
D1239
 
Peginterferon beta-1a
 
NA
 
NA
Moderate    Inter Info   
[199], [200], [201], [202]
D1589
 
Tioguanine
 
C5H5N5S
 
2723601 
Moderate    Inter Info   
[306], [307]
D1615
 
Trabectedin
 
C39H43N3O11S
 
108150 
Moderate    Inter Info   
[6], [312]
      Pharmacodynamic antagonistic effects
   Attenuated pharmacological effects (Unspecific) Drug Num:  13
Drug ID
 
Drug Name
Formula Pubchem ID Severity Level Interaction Detail REF
D0387
 
Conjugated estrogens
 
C18H21NaO5S
 
45357473 
Moderate    Inter Info   
[1], [78], [79]
D0388
 
Conjugated estrogens (topical)
 
C18H21NaO5S
 
45357473 
Moderate    Inter Info   
[1], [78], [79]
D0484
 
Dienestrol (topical)
 
C18H18O2
 
667476 
Moderate    Inter Info   
[1], [78], [79]
D0487
 
Diethylstilbestrol
 
C18H20O2
 
448537 
Moderate    Inter Info   
[1], [78], [79]
D1327
 
Prasterone enantate
 
C26H40O3
 
163331 
Moderate    Inter Info   
[1], [78], [79]
D0605
 
Esterified estrogens
 
NA
 
NA
Moderate    Inter Info   
[1], [78], [79]
D0606
 
Estradiol
 
C18H24O2
 
5757 
Moderate    Inter Info   
[1], [78], [79]
D0607
 
Estradiol (topical)
 
C18H24O2
 
5757 
Moderate    Inter Info   
[1], [78], [79]
D0609
 
Estrone
 
C18H22O2
 
5870 
Moderate    Inter Info   
[1], [78], [79]
D0610
 
Estrone sulfate
 
C18H22O5S
 
3001028 
Moderate    Inter Info   
[1], [78], [79]
D0611
 
Estrone sulfate (topical)
 
C18H22O5S
 
3001028 
Moderate    Inter Info   
[1], [78], [79]
D0619
 
Ethinylestradiol
 
C20H24O2
 
5991 
Moderate    Inter Info   
[1], [78], [79]
D1370
 
Quinestrol
 
C25H32O2
 
9046 
Moderate    Inter Info   
[1], [78], [79]
References
1 Product Information. Orilissa (elagolix). AbbVie US LLC, North Chicago, IL.
2 Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
3 Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
4 Canadian Pharmacists Association.
5 Cerner Multum, Inc. "Australian Product Information.".
6 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
7 Product Information. Butorphanol Tartrate (butorphanol). Apotex Corporation, Weston, FL.
8 Product Information. Duragesic Transdermal System (fentanyl). Janssen Pharmaceutica, Titusville, NJ.
9 Product Information. Ionsys (fentanyl). Ortho McNeil Pharmaceutical, Raritan, NJ.
10 Product Information. Mycobutin (rifabutin). Pharmacia and Upjohn, Kalamazoo, MI.
11 Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
12 Product Information. Rifadin (rifampin). Hoechst Marion-Roussel Inc, Kansas City, MO.
13 Product Information. Zohydro ER (HYDROcodone). Zogenix, Inc, San Diego, CA.
14 Mendell J, Zahir H, Matsushima N, et al. "Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor." Am J Cardiovasc Drugs (2013):. [PMID: 23784266]
15 Parasrampuria DA, Mendell J, Shi M, Matsushima N, Zahir H, Truitt K "Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine." Br J Clin Pharmacol 0 (2016): epub. [PMID: 27530188]
16 Product Information. Savaysa (edoxaban). Daiichi Sankyo, Inc., Parsippany, NJ.
17 Ace LN, Jaffe JM, Kunka RL "Effect of food and an antacid on quinidine bioavailability." Biopharm Drug Dispos 4 (1983): 183-90. [PMID: 6882885]
18 Min DI, Ku YM, Geraets DR, Lee HC "Effect of grapefruit juice on the pharmacokinetics and pharmacodynamics of quinidine in healthy volunteers." J Clin Pharmacol 36 (1996): 469-76. [PMID: 8739026]
19 Product Information. Orladeyo (berotralstat). BioCryst Pharmaceuticals Inc, Durham, NC.
20 Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
21 Product Information. Tazverik (tazemetostat). Epizyme, Inc, Cambridge, MA.
22 Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
23 EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
24 Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
25 Patel S, Robinson R, Burk M "Hypertensive crisis associated with St. John's Wort." Am J Med 112 (2002): 507-8. [PMID: 11959071]
26 Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
27 Product Information. Juxtapid (lomitapide). Aegerion Pharmaceuticals Inc, Cambridge, MA.
28 Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
29 Product Information. Caplyta (lumateperone). Intra-Cellular Therapies, Inc., New York, NY.
30 Altice FL, Friedland GH, Cooney EL "Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone." AIDS 13 (1999): 957-62. [PMID: 10371177]
31 Bell J, Seres V, Bowron P, Lewis J, Batey R "The use of serum methadone levels in patients receiving methadone maintenance." Clin Pharmacol Ther 43 (1988): 623-9. [PMID: 3378383]
32 Bending MR, Skacel PO "Rifampicin and methadone withdrawal." Lancet 1 (1977): 1211. [PMID: 68314]
33 Finelli PF "Phenytoin and methadone tolerance." N Engl J Med 294 (1976): 227. [PMID: 1244546]
34 Holmes VF "Rifampin-induced methadone withdrawal in AIDS." J Clin Psychopharmacol 10 (1991): 443-4. [PMID: 2286719]
35 Kreek MJ, Garfield JW, Gutjahr CL, Giusti LM "Rifampin-induced methadone withdrawal." N Engl J Med 294 (1976): 1104-6. [PMID: 1256526]
36 Liu S-J, Wang RI "Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome." Am J Psychiatry 141 (1984): 1287-8. [PMID: 6486271]
37 Otero MJ, Fuertes A, Sanchez R, Luna G "Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert." AIDS 13 (1999): 1004-5. [PMID: 10371190]
38 Pinzani V, Faucherre V, Peyriere H, Blayac JP "Methadone withdrawal symptoms with nevirapine and efavirenz." Ann Pharmacother 34 (2000): 405-7. [PMID: 10917395]
39 Product Information. Diskets (methadone). Cebert Pharmaceuticals Inc, Birmingham, AL.
40 Raistrick D, Hay A, Wolff K "Methadone maintenance and tuberculosis treatment." BMJ 313 (1996): 925-6. [PMID: 8876100]
41 Tong TG, Pond SM, Kreek MJ, et al "Phenytoin-induced methadone withdrawal." Ann Intern Med 94 (1981): 349-51. [PMID: 7224382]
42 Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
43 Product Information. Orgovyx (relugolix). Myovant Sciences, Inc., Brisbane, CA.
44 Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
45 Kharasch ED, Thummel KE "Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?" Anesth Analg 76 (1993): 1033-9. [PMID: 8484504]
46 Koehntop DE, Noormohamed SE, Fletcher CV "Effects of long-term drugs on alfentanil clearance in patients undergoing renal transplantation." Pharmacotherapy 14 (1994): 592-9. [PMID: 7997393]
47 Labroo RB, Thummel KE, Kunze KL, Podoll T, Trager WF, Kharasch ED "Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism." Drug Metab Dispos 23 (1995): 490-6. [PMID: 7600917]
48 Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, Cox K "The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions." Anesthesiology 87 (1997): 36-50. [PMID: 9232132]
49 Product Information. Reyataz (atazanavir). Bristol-Myers Squibb, Princeton, NJ.
50 Sommadossi JP "HIV protease inhibitors: pharmacologic and metabolic distinctions." AIDS 13 (1999): s29-40. [PMID: 10546783]
51 Durant J, Clevenbergh P, Garraffo R, Halfon P, Icard S, DelGiudice P, Montagne N, Schapiro JM, Dellamonica P "Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study." Aids 14 (2000): 1333-9. [PMID: 10930147]
52 Product Information. Otezla (apremilast). Celgene Corporation, Summit, NJ.
53 Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
54 Product Information. Coartem (artemether-lumefantrine). Novartis Pharmaceuticals, East Hanover, NJ.
55 Bullman J, Nicholls A, Van Landingham K, et al. "Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers." Epilepsia 52 (2011): 1351-8. [PMID: 21635243]
56 Gerber JG, Rosenkranz SL, Fichtenbaum CJ, et al. "Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study." J Acquir Immune Defic Syndr 39 (2005): 307-12. [PMID: 15980690]
57 Khandwala HM "Lipid lowering inefficacy of high-dose statin therapy due to concurrent use of phenytoin." South Med J 99 (2006): 1385-7. [PMID: 17233196]
58 Murphy MJ, Dominiczak MH "Efficacy of statin therapy: possible effect of phenytoin." Postgrad Med J 75 (1999): 359-60. [PMID: 10435174]
59 Product Information. Lipitor (atorvastatin). Parke-Davis, Morris Plains, NJ.
60 Product Information. Stendra (avanafil). Vivus Inc, Mountain View, CA.
61 Pithavala YK, Tortorici M, Toh M, et al "Effect of rifampin on the pharmacokinetics of axitinib (AG-013736) in Japanese and Caucasian healthy volunteers." Cancer Chemother Pharmacol 65 (2010): 563-70. [PMID: 19603168]
62 Product Information. Inlyta (axitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
63 Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
64 Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
65 Product Information. Adcetris (brentuximab vedotin). Seattle Genetics Inc, Bothell, WA.
66 Product Information. Buprenex (buprenorphine). Reckitt and Colman Pharmaceutical, Richmond, VA.
67 Kivisto KT, Lamberg TS, Neuvonen PJ "Interactions of buspirone with itraconazole and rifampicin: Effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone." Pharmacol Toxicol 84 (1999): 94-7. [PMID: 10068153]
68 Lamberg TS, Kivisto KT, Neuvonen PJ "Concentrations and effects of buspirone are considerably reduced by rifampicin." Br J Clin Pharmacol 45 (1998): 381-5. [PMID: 9578186]
69 Product Information. Buspar (buspirone). Bristol-Myers Squibb, Princeton, NJ.
70 Product Information. Jevtana (cabazitaxel). sanofi-aventis , Bridgewater, NJ.
71 Product Information. Cabometyx (cabozantinib). Exelixis Inc, S San Francisco, CA.
72 Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
73 Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
74 Product Information. Tabrecta (capmatinib). Novartis Pharmaceuticals, East Hanover, NJ.
75 Product Information. Cancidas (caspofungin) Merck & Co, Inc, West Point, PA.
76 Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
77 Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
78 Schubert W, Eriksson U, Edgar B, Cullberg G, Hedner T "Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17B-estradiol." Eur J Drug Metab Pharmacokinet 20 (1995): 219-24. [PMID: 8751044]
79 Weber A, Jager R, Borner A, et al. "Can grapefruit juice influence ethinyl estradiol bioavailability?" Contraception 53 (1996): 41-7. [PMID: 8631189]
80 Cerner Multum, Inc. "Canadian Product Information.".
81 Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
82 Product Information. Tafinlar (dabrafenib). GlaxoSmithKline, Research Triangle Park, NC.
83 Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
84 Acosta EP, Henry K, Baken L, Page LM, Fletcher CV "Indinavir concentrations and antiviral effect." Pharmacotherapy 19 (1999): 708-12. [PMID: 10391416]
85 Barry M, Gibbons S, Back D, Mulcahy F "Protease inhibitors in patients with HIV disease. Clinically important pharmacokinetic considerations." Clin Pharmacokinet 32 (1997): 194-209. [PMID: 9084959]
86 Brooks J, Daily J, Schwamm L "Protease inhibitors and anticonvulsants." AIDS Clin Care 9 (1997): 87,90. [PMID: 11364776]
87 Hugen PWH, Burger DM, Brinkman K, terHofstede HJM, Schuurman R, Koopmans PP, Hekster YA "Carbamazepine-indinavir interaction causes antiretroviral therapy failure." Ann Pharmacother 34 (2000): 465-70. [PMID: 10772431]
88 Liedtke MD, Lockhart SM, Rathbun RC "Anticonvulsant and antiretroviral interactions." Ann Pharmacother 38 (2004): 482-9. [PMID: 14970370]
89 Product Information. Agenerase (amprenavir). Glaxo Wellcome, Research Triangle Pk, NC.
90 Product Information. Aptivus (tipranavir). Boehringer-Ingelheim, Ridgefield, CT.
91 Product Information. Crixivan (indinavir). Merck & Co, Inc, West Point, PA.
92 Product Information. Fortovase (saquinavir) Roche Laboratories, Nutley, NJ.
93 Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
94 Product Information. Lexiva (fosamprenavir). GlaxoSmithKline, Research Triangle Park, NC.
95 Product Information. Prezista (darunavir). Ortho Biotech Inc, Bridgewater, NJ.
96 Product Information. Viracept (nelfinavir). Agouron Pharma Inc, La Jolla, CA.
97 Product Information. Sprycel (dasatinib). Bristol-Myers Squibb, Princeton, NJ.
98 Multum Information Services, Inc. Expert Review Panel.
99 Product Information. Cerubidine (daunorubicin). Wyeth-Ayerst Laboratories, Philadelphia, PA.
100 Product Information. Daunoxome (daunorubicin liposomal). Nexstar Pharmaceuticals Inc, Boulder, CO.
101 Product Information. Idamycin (idarubicin). Pharmacia and Upjohn, Kalamazoo, MI.
102 Product Information. Methergine (methylergonovine). Novartis Pharmaceuticals, East Hanover, NJ.
103 Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
104 Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
105 Baciewicz AM "Oral contraceptive drug interactions." Ther Drug Monit 7 (1985): 26-35. [PMID: 2859674]
106 Baciewicz AM, Self TH "Rifampin drug interactions." Arch Intern Med 144 (1984): 1667-71. [PMID: 6380442]
107 Back DJ, Bates M, Bowden A, et al "The interaction of phenobarbital and other anticonvulsants with oral contraceptive steroid therapy." Contraception 22 (1980): 495-503. [PMID: 7471739]
108 Back DJ, Breckenridge AM, Crawford FE, et al. "The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women." Contraception 21 (1980): 135-43. [PMID: 7189454]
109 Back DJ, Breckenridge AM, Crawford FE, MacIver M, Orne ML, Rowe PH "Interindividual variation and drug interactions with hormonal steroid contraceptives." Drugs 21 (1981): 46-61. [PMID: 7009137]
110 Back DJ, Orme ML "Pharmacokinetic drug interactions with oral contraceptives." Clin Pharmacokinet 18 (1990): 472-84. [PMID: 2191822]
111 Barditch-Crovo P, Trapnell CB, Ette E, et al "The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive." Clin Pharmacol Ther 65 (1999): 428-38. [PMID: 10223781]
112 Bolt HM, Bolt M, Kappus H "Interaction of rifampicin treatment with pharmacokinetics and metabolism of ethinyloestradiol in man." Acta Endocrinol (Copenh) 85 (1977): 189-97. [PMID: 577076]
113 Borcherding SM, Baciewicz AM, Self TH "Update on rifampin drug interactions." Arch Intern Med 152 (1992): 711-6. [PMID: 1558427]
114 Cote J "Interaction of griseofulvin and oral contraceptives." J Am Acad Dermatol 22 (1990): 124-5. [PMID: 2298948]
115 Coulam CB, Annegers JF "Do anticonvulsants reduce the efficacy of oral contraceptives?" Epilepsia 20 (1979): 519-26. [PMID: 477641]
116 Crawford P, Chadwick DJ, Martin C, et al "The interaction of phenytoin and carbamazepine with combined oral contraceptive steroids." Br J Clin Pharmacol 30 (1990): 892-6. [PMID: 2126946]
117 Curran MA "Drug interactions with the pill." Med J Aust 144 (1986): 670-1. [PMID: 3086681]
118 D'Arcy PF "Drug interactions with oral contraceptives." Drug Intell Clin Pharm 20 (1986): 353-62. [PMID: 3519141]
119 Dickinson BD, Altman RD, Nielsen NH, Sterling ML "Drug interactions between oral contraceptives and antibiotics." Obstet Gynecol 98(5 Pt 1) (2001): 853-60. [PMID: 11704183]
120 D'Arcy PF. Drug interactions with oral contraceptives. Drug Intell Clin Pharm. 1986;20(5):353-362. [PMID: 3519141]
121 Durr D, Stieger B, KullakUblick GA, Rentsch KM, Steinert HC, Meier PJ, Fattinger K "St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4." Clin Pharmacol Ther 68 (2000): 598-604. [PMID: 11180019]
122 Faculty of Sexual & Reproductive Healthcare "FSRH Clinical Guidance: Drug Interactions with Hormonal Contraception.".
123 Furlan AJ, Rothner AD "Anti-epileptic drugs and failure of oral contraceptives." Lancet 1 (1974): 1113. [PMID: 4135275]
124 Gorski JC, Hamman MA, Wang Z, Vasvada N, Huang S, Hall SD "The effect of St. John's wort on the efficacy of oral contraception." Clin Pharmacol Ther 71 (2002): P25. [PMID: 14663455]
125 Hall SD, Wang Z, Huang SM, et al. "The interaction between St John's wort and an oral contraceptive." Clin Pharmacol Ther 74 (2003): 525-35. [PMID: 14663455]
126 Halpenny O, Bye A, Cranny A, Feely J, Daly PA "Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate." Med Oncol Tumor Pharmacother 7 (1990): 241-7. [PMID: 2149401]
127 Janz D, Schmidt D "Letter: Anti-epileptic drugs and failure of oral contraceptives." Lancet 1 (1974): 1113. [PMID: 4135275]
128 Klosterskov Jensen P, Saano V, Haring P, Svenstrup B, Menge GP "Possible interaction between oxcarbazepine and an oral contraceptive." Epilepsia 33 (1992): 1149-52. [PMID: 1464278]
129 Laengner H, Detering K "Letter: Anti-epileptic drugs and failure of oral contraceptives." Lancet 2 (1974): 600. [PMID: 4140317]
130 LeBel M, Masson E, Guilbert E, Colborn D, Paquet F, Allard S, Vallee F, Narang PK "Effects of rifabutin and rifampicin on the pharmacokinetics of ethinylestradiol and norethindrone." J Clin Pharmacol 38 (1998): 1042-50. [PMID: 9824786]
131 Mattson RH, Cramer JA, Darney PD, Naftolin F "Use of oral contraceptives by women with epilepsy." JAMA 256 (1986): 238-40. [PMID: 3723710]
132 McDaniel PA, Caldroney RD "Oral contraceptives and griseofulvin interaction." Drug Intell Clin Pharm 20 (1986): 384. [PMID: 3709350]
133 Michalets EL "Update: clinically significant cytochrome P-450 drug interactions." Pharmacotherapy 18 (1998): 84-112. [PMID: 9469685]
134 Mumford JP "Letter: Drugs affecting oral contraceptives." Br Med J 2 (1974): 333-4. [PMID: 4827122]
135 Nocke-finck L "Effects of rifampicin on menstral cycle and on estrogen excretion in patients taking oral contraceptives." JAMA 226 (1973): 378. [PMID: 4580141]
136 Notelovitz M, Tjapkes J, Ware M "Interaction between estrogen and dilantin in a menopausal woman." N Engl J Med 304 (1981): 788-9. [PMID: 6258075]
137 Pfrunder A, Schiesser M, Gerber S, Haschke M, Bitzer J, Drewe J "Interaction of St John's wort with low-dose oral contraceptive therapy: a randomized controlled trial." Br J Clin Pharmacol 56 (2003): 683-90. [PMID: 14616430]
138 Product Information. Premarin (conjugated estrogens). Wyeth-Ayerst Laboratories, Philadelphia, PA.
139 Murphy PA. St. John's wort and oral contraceptives: reasons for concern?.?J Midwifery Womens Health. 2002;47(6):447-450. doi:10.1016/s1526-9523(02)00321-5. [PMID: 12484666]
140 Skolnick JL, Stoler BS, Katz DB, Anderson WH "Rifampin, oral contraceptives, and pregnancy." JAMA 236 (1976): 1382. [PMID: 989097]
141 Strayhorn VA, Baciewicz AM, Self TH "Update on rifampin drug interactions, III." Arch Intern Med 157 (1997): 2453-8. [PMID: 9385296]
142 Szoka PR, Edgren RA "Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database." Fertil Steril 49 (1988): s31-8. [PMID: 3282933]
143 Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. Br J Clin Pharmacol 55 (2003): 112-113. [PMID: 12534648]
144 van Dijke CP, Weber JC "Interaction between oral contraceptives and griseofulvin." Br Med J (Clin Res Ed) 288 (1984): 1125-6. [PMID: 2143563]
145 Venkatesan K "Pharmacokinetic drug interactions with rifampicin." Clin Pharmacokinet 22 (1992): 47-65. [PMID: 1559307]
146 Weaver K, Glasier A "Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill: a literature review." Contraception 59 (1999): 71-8. [PMID: 10361620]
147 Weber JC "Interaction between oral contraceptives and griseofulvin." Br Med J 288 (1984): 1125-6. [PMID: 6424759]
148 Weisberg E "Interactions between oral contraceptives and antifungals antibacterials - Is contraceptive failure the result?." Clin Pharmacokinet 36 (1999): 309-13. [PMID: 10384856]
149 Wilbur K, Ensom MHH "Pharmacokinetic drug interactions between oral contraceptives and second-generation anticonvulsants." Clin Pharmacokinet 38 (2000): 355-65. [PMID: 10803456]
150 Zachariassen RD "Loss of oral contraceptive efficacy by concurrent antibiotic administration." Women Health 22 (1994): 17-26. [PMID: 7900401]
151 Lundgren S, Lonning PE, Aakvaag A, Kvinnsland S, Lnning PE "Influence of aminoglutethimide on the metabolism of medroxyprogesterone acetate and megestrol acetate in postmenopausal patients with advanced breast cancer." Cancer Chemother Pharmacol 27 (1990): 101-5. [PMID: 2249324]
152 Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
153 Product Information. Verzenio (abemaciclib). Lilly, Eli and Company, Indianapolis, IN.
154 Product Information. Piqray (alpelisib). Novartis Pharmaceuticals, East Hanover, NJ.
155 Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
156 Product Information. Bevyxxa (betrixaban). Portola Pharmaceuticals, South San Francisco, CA.
157 Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
158 Product Information. Aliqopa (copanlisib). Bayer Pharmaceutical Inc, West Haven, CT.
159 Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
160 Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
161 EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
162 Product Information. Rozlytrek (entrectinib). Genentech, South San Francisco, CA.
163 Product Information. Diabinese (chlorpropamide). Pfizer US Pharmaceuticals, New York, NY.
164 Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
165 Skillman TG, Feldman JM "The pharmacology of sulfonylureas." Am J Med 70 (1981): 361-72. [PMID: 6781341]
166 Product Information. Xospata (gilteritinib). Astellas Pharma US, Inc, Deerfield, IL.
167 Product Information. Mavyret (glecaprevir-pibrentasvir). Abbott Pharmaceutical, Abbott Park, IL.
168 Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
169 Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
170 Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
171 Product Information. Pemazyre (pemigatinib). Incyte Corporation, Wilmington, DE.
172 European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
173 Gilead Sciences, Inc "About Remdesivir.".
174 US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
175 Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
176 Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
177 Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
178 Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
179 Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
180 Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
181 Product Information. Vitekta (elvitegravir). Gilead Sciences, Foster City, CA.
182 Product Information. Braftovi (encorafenib). Array BioPharma Inc., Boulder, CO.
183 Li J, Zhao M, He P, Hidalgo M, Baker SD "Differential metabolism of gefitinib and erlotinib by human cytochrome p450 enzymes." Clin Cancer Res 13 (2007): 3731-7. [PMID: 17575239]
184 Product Information. Tarceva (erlotinib). Genentech, South San Francisco, CA.
185 Product Information. Lunesta (eszopiclone). Sepracor Inc, Marlborough, MA.
186 Product Information. Intelence (etravirine). Ortho Biotech Inc, Bridgewater, NJ.
187 Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
188 Product Information. Aromasin (exemestane) Pharmacia & Upjohn, Kalamazoo, MI.
189 Product Information. Toviaz (fesoterodine). Pfizer U.S. Pharmaceuticals Group, New York, NY.
190 Product Information. Addyi (flibanserin). Sprout Pharmaceuticals, Raleigh, NC.
191 Product Information. Iressa (gefitinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
192 Product Information. Daurismo (glasdegib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
193 Kiechel JR, Lavene D, Guerret M, Comoy E, Godin M, Fillastre JP "Pharmacokinetic aspects of guanfacine withdrawal syndrome in a hypertensive patient with chronic renal failure." Eur J Clin Pharmacol 25 (1983): 463-6. [PMID: 6360692]
194 Product Information. Intuniv (guanfacine). Shire US Inc, Florence, KY.
195 Product Information. Imbruvica (ibrutinib). Pharmacyclics Inc, Sunnyvale, CA.
196 Bolton AE, Peng B, Hubert M, et al. "Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects." Cancer Chemother Pharmacol 53 (2004): 102-6. [PMID: 14605865]
197 EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
198 Product Information. Gleevec (imatinib mesylate). Novartis Pharmaceuticals, East Hanover, NJ.
199 Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
200 Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
201 Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
202 Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
203 Crews KR, Stewart CF, Jones-Wallace D, et al "Altered irinotecan pharmacokinetics in pediatric high-grade glioma patients receiving enzyme-inducing anticonvulsant therapy." Clin Cancer Res 8 (2002): 2202-9. [PMID: 12114421]
204 Di YM, Li CG, Xue CC, Zhou SF "Clinical drugs that interact with St. John's wort and implication in drug development." Curr Pharm Des 14 (2008): 1723-42. [PMID: 18673195]
205 Friedman HS, Petros WP, Friedman AH, et al "Irinotecan therapy in adults with recurrent or progressive malignant glioma." J Clin Oncol 17 (1999): 1516-25. [PMID: 10334539]
206 Innocenti F, Undevia SD, Ramirez J, et al. "A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital." Clin Pharmacol Ther 76 (2004): 490-502. [PMID: 15536463]
207 Kuhn JG "Influence of anticonvulsants on the metabolism and elimination of irinotecan. A North American Brain Tumor Consortium preliminary report." Oncology (Williston Park 16(8 Suppl 7) (2002): 33-40. [PMID: 12199631]
208 Hu ZP, Yang XX, Chen X, et al. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.?Curr Drug Metab. 2007;8(2):157-171. [PMID: 17305494]
209 Mathijssen RH, Verweij J, De Bruijn P, Loos WJ, Sparreboom A "Effects of St. John's Wort on Irinotecan Metabolism." J Natl Cancer Inst 94 (2002): 1247-9. [PMID: 12189228]
210 Minami H, Lad TE, Nicholas MK, Vokes EE, Ratain MJ "Pharmacokinetics and pharmacodynamics of 9-aminocamptothecin infused over 72 hours in phase II studies." Clin Cancer Res 5 (1999): 1325-30. [PMID: 10389915]
211 Murry DJ, Cherrick I, Salama V, et al. "Influence of phenytoin on the disposition of irinotecan: a case report." J Pediatr Hematol Oncol 24 (2002): 130-3. [PMID: 11990699]
212 Product Information. Camptosar (irinotecan). Pharmacia and Upjohn, Kalamazoo, MI.
213 Product Information. Onivyde (irinotecan liposomal). Merrimack Pharmaceuticals, Cambridge, MA.
214 Hofland KF, Hansen S, Sorensen M, et al. Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.?Acta Oncol. 2014;53(7):939-944. [PMID: 24456504]
215 Santos A, Zanetta S, Cresteil T, et al "Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans." Clin Cancer Res 6 (2000): 2012-20. [PMID: 10815927]
216 Yonemori K, Takeda Y, Toyota E, Kobayashi N, Kudo K "Potential interactions between irinotecan and rifampin in a patient with small-cell lung cancer." Int J Clin Oncol 9 (2004): 206-9. [PMID: 15221608]
217 Zamboni WC, Gajjar AJ, Heideman RL, et al "Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma." Clin Cancer Res 4 (1998): 783-9. [PMID: 9533548]
218 Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
219 Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
220 Product Information. Orkambi (ivacaftor-lumacaftor). Vertex Pharmaceuticals, Cambridge, MA.
221 Product Information. Symdeko 4-Week (ivacaftor-tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
222 Product Information. Trikafta (elexacaftor/ivacaftor/tezacaftor). Vertex Pharmaceuticals, Cambridge, MA.
223 Product Information. Ixempra (ixabepilone). Bristol-Myers Squibb, Princeton, NJ.
224 Product Information. Ninlaro (ixazomib). Takeda Pharmaceuticals America, Lincolnshire, IL.
225 Product Information. Tykerb (lapatinib). Novartis Pharmaceuticals, East Hanover, NJ.
226 Product Information. Tradjenta (linagliptin). Boehringer Ingelheim, Ridgefield, CT.
227 Product Information. Latuda (lurasidone). Sunovion Pharmaceuticals Inc, Marlborough, MA.
228 Bruderer S, Aanismaa P, Homery MC, et al. "Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist." AAPS J 14 (2012): 68-78. [PMID: 22189899]
229 Product Information. Opsumit (macitentan). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
230 Product Information. Selzentry (maraviroc). Pfizer U.S. Pharmaceuticals Group, New York, NY.
231 Kobayashi K, Mimura N, Fujii H, et al "Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate." Clin Cancer Res 6 (2000): 3297-303. [PMID: 10955816]
232 Product Information. Provera (medroxyprogesterone). Pharmacia and Upjohn, Kalamazoo, MI.
233 Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
234 Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
235 Dutreix C, Munarini F, Lorenzo S, Roesel J, Wang Y "Investigation into CYP3A4-mediated drug-drug interactions on midostaurin in healthy volunteers." Cancer Chemother Pharmacol 72 (2013): 1223-34. [PMID: 24085261]
236 Product Information. Rydapt (midostaurin). Novartis Pharmaceuticals, East Hanover, NJ.
237 Product Information. Remeron (mirtazapine). Organon, West Orange, NJ.
238 Sitsen JM, Maris FA, Timmer CJ "Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects." Eur J Drug Metab Pharmacokinet 26 (2001): 109-21. [PMID: 11554425]
239 Spaans E, Van Den Heuvel MW, Schnabel PG, et al. "Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects." Eur J Clin Pharmacol 58 (2002): 423-9. [PMID: 12242602]
240 Timmer CJ, Sitsen JMA, Delbressine LP "Clinical pharmacokinetics of mirtazapine." Clin Pharmacokinet 38 (2000): 461-74. [PMID: 10885584]
241 Product Information. Singulair (montelukast). Merck & Co, Inc, West Point, PA.
242 Product Information. Symproic (naldemedine). Shionogi USA Inc, Florham Park, NJ.
243 Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
244 Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
245 Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
246 Product Information. Lynparza (olaparib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
247 Product Information. Isturisa (osilodrostat). Recordati Rare Diseases Inc, Lebanon, NJ.
248 Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
249 Jamis-Dow CA, Klecker RW, Katki AG, Collins JM "Metabolism of Taxol by human liver microsomes and effect of inhibitors (Meeting abstract)." Proc Annu Meet Am Assoc Cancer Res 34 (1993): a21981993.
250 Product Information. Abraxane (paclitaxel protein-bound). American Pharmaceutical Partners, Schaumberg, IL.
251 Product Information. Taxol (paclitaxel). Bristol-Myers Squibb, Princeton, NJ.
252 Spencer CM, Faulds D "Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer." Drugs 48 (1994): 794-847. [PMID: 7530632]
253 Product Information. Ibrance (palbociclib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
254 Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
255 Product Information. Votrient (pazopanib). GlaxoSmithKline, Research Triangle Park, NC.
256 Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
257 Product Information. Nuplazid (pimavanserin). Accelis Pharma, East Windsor, NJ.
258 Product Information. Iclusig (ponatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
259 Bittencourt PR, Gracia CM, Martins R, et al "Phenytoin and carbamazepine decrease oral bioavailability of praziquantel." Neurology 42 (1992): 492-6. [PMID: 1549207]
260 Product Information. Biltricide (praziquantel). Bayer, West Haven, CT.
261 Ridtitid W, Wongnawa M, Mahatthanatrakul W, Punyo J, Sunbhanich M "Rifampin markedly decreases plasma concentrations of praziquantel in healthy volunteers." Clin Pharmacol Ther 72 (2002): 505-13. [PMID: 12426514]
262 Grimm SW, Richtand NM, Winter HR, Stams KR, Reele SB "Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics." Br J Clin Pharmacol 61 (2006): 58-69. [PMID: 16390352]
263 Product Information. Seroquel (quetiapine). Zeneca Pharmaceuticals, Wilmington, DE.
264 Quetiapine for schizophrenia. Med Lett Drugs Ther 39 (1997): 117-8. [PMID: 9422044]
265 Wong YWJ, Yeh C, Thyrum PT "The effects of concomitant phenytoin administration on the steady-state pharmacokinetics of quetiapine." J Clin Psychopharmacol 21 (2001): 89-93. [PMID: 11199955]
266 Fabre C, Criddle J, Nolder D, Klein JL "Recrudescence of imported falciparum malaria after quinine therapy: potential drug interaction with phenytoin." Trans R Soc Trop Med Hyg 99 (2005): 871-3. [PMID: 16099004]
267 Product Information. Qualaquin (quinine). AR Scientific Inc, Philadelphia, PA.
268 Pukrittayakamee S, Prakongpan S, Wanwimolruk S, Clemens R, Looareesuwan S, White NJ "Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria." Antimicrob Agents Chemother 47 (2003): 1509-1513. [PMID: 12709315]
269 Twum-Barima Y, Carruthers SG "Quinidine-rifampin interaction." N Engl J Med 304 (1981): 1466-9. [PMID: 7231477]
270 Wanwimolruk S, Kang W, Coville PF, Viriyayudhakorn S, Thitiarchakul S "Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man." Br J Clin Pharmacol 40 (1995): 87-91. [PMID: 8527275]
271 Product Information. Rozerem (ramelteon). Takeda Pharmaceuticals America, Lincolnshire, IL.
272 Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT "CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide." Br J Clin Pharmacol 56 (2003): 305-14. [PMID: 12919179]
273 Niemi M, Backman JT, Neuvonen M, Neuvonen PJ, Kivisto KT "Rifampin decreases the plasma concentrations and effects of repaglinide." Clin Pharmacol Ther 68 (2000): 495-500. [PMID: 11103752]
274 Product Information. Prandin (repaglinide). Novo Nordisk Pharmaceuticals Inc, Princeton, NJ.
275 Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
276 Product Information. Edurant (rilpivirine). Tibotec Pharmaceuticals, Titusville, NJ.
277 Product Information. Adempas (riociguat). Bayer Pharmaceutical Inc, West Haven, CT.
278 Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
279 Product Information. Jakafi (ruxolitinib). Incyte Corporation, Wilmington, DE.
280 Product Information. Onglyza (saxagliptin). Bristol-Myers Squibb, Princeton, NJ.
281 Product Information. Koselugo (selumetinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
282 Hyland R, Roe GH, Jones BC, Smith DA "Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil." Br J Clin Pharmaacol 51 (2001): 239-48. [PMID: 11298070]
283 Product Information. Revatio (sildenafil). Pfizer U.S. Pharmaceuticals Group, New York, NY.
284 Product Information. Viagra (sildenafil). Pfizer US Pharmaceuticals, New York, NY.
285 Warrington JS, Shader RI, vonMoltke LL, Greenblatt DJ "In vitro biotransformation of sildenafil (Viagra): Identification of human cytochromes and potential drug interactions." Drug Metab Disposition 28 (2000): 392-7. [PMID: 10725306]
286 Product Information. Prograf (tacrolimus). Fujisawa, Deerfield, IL.
287 Product Information. Rapamune (sirolimus) Wyeth-Ayerst Laboratories, Philadelphia, PA.
288 Product Information. VESIcare (solifenacin). GlaxoSmithKline, Research Triangle Park, NC.
289 Product Information. Odomzo (sonidegib). Novartis Pharmaceuticals, East Hanover, NJ.
290 Product Information. Nexavar (sorafenib). Bayer Pharmaceutical Inc, West Haven, CT.
291 Product Information. Diacomit (stiripentol). Biocodex Inc, Creswell, OR.
292 Product Information. Sutent (sunitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
293 Product Information. Belsomra (suvorexant). Merck & Company Inc, Whitehouse Station, NJ.
294 Product Information. Adcirca (tadalafil). United Therapeutics Corporation, Silver Spring, MD.
295 Product Information. Cialis (tadalafil). Lilly, Eli and Company, Indianapolis, IN.
296 Product Information. Talzenna (talazoparib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
297 Biochem Pharmacol "Variable contribution of cytochromes P450 2D6, 2C9, and 3A4 to the 4-hydroxylation of tamoxifen by human liver microsomes." Biochem Pharmacol 53 (1997): 171-8. [PMID: 9037249]
298 Kivisto KT, Villikka K, Nyman L, Anttila M, Neuvonen PJ "Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin." Clin Pharmacol Ther 64 (1998): 648-54. [PMID: 9871429]
299 Lien EA, Anker G, Lonning PE, et al "Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide." Cancer Res 50 (1990): 5851-7. [PMID: 2393854]
300 Product Information. Targretin (bexarotene) Ligand Pharmaceuticals, San Diego, CA.
301 Product Information. Hetlioz (tasimelteon). Vanda Pharmaceuticals Inc, Rockville, MD.
302 Product Information. Torisel (temsirolimus). Wyeth-Ayerst Laboratories, Philadelphia, PA.
303 Product Information. Brilinta (ticagrelor). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
304 Teng R, Mitchell P, Butler K "Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects." Eur J Clin Pharmacol 69 (2013): 877-83. [PMID: 23093043]
305 Weeks P, Sieg A, Vahdat K, Raissi F, Nathan S "Improved ticagrelor antiplatelet effect on discontinuation of phenytoin." Ann Pharmacother 48 (2014): 644-7. [PMID: 24477376]
306 Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
307 Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
308 Product Information. Xeljanz (tofacitinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
309 Product Information. Samsca (tolvaptan). Otsuka American Pharmaceuticals Inc, Rockville, MD.
310 Berthou F, Dreano Y, Belloc C, Kangas L, Gautier JC, Beaune P "Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes." Biochem Pharmacol 47 (1994): 1883-95. [PMID: 8204106]
311 Product Information. Fareston (toremifene). Schering Laboratories, Kenilworth, NJ.
312 Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
313 Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
314 Product Information. Viibryd (vilazodone). Trovis Pharmaceuticals LLC, New Haven, CT.
315 Product Information. Brintellix (vortioxetine). Takeda Pharmaceuticals America, Lincolnshire, IL.
316 Hellmann A, Rule S, Walewski J, et al. "Effect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or Non-Hodgkin's lymphoma." Clin Pharmacokinet 50 (2011): 781-91. [PMID: 22087865]
317 Pekol T, Daniels JS, Labutti J, et al "Human metabolism of the proteasome inhibitor bortezomib: identification of circulating metabolites." Drug Metab Dispos 33 (2005): 771-7. [PMID: 15764713]
318 Product Information. Velcade (bortezomib). Millennium Pharmaceuticals Inc, Cambridge, MA.
319 Uttamsingh V, Lu C, Miwa GT, Gan LS "Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4 to the hepatic metabolism of teh protosome inhibitor bortezomib." Drug Metab Dispos 33 (2005): 1723-8. [PMID: 16103134]
320 Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
321 Product Information. Aczone (dapsone topical). QLT USA, Inc, Fort Collins, CO.
322 Product Information. Tivicay (dolutegravir). ViiV Healthcare, Research Triangle Park, NC.
323 Product Information. Dificid (fidaxomicin). Optimer Pharmaceuticals, San Diego, CA.
324 Product Information. Rukobia (fostemsavir). ViiV Healthcare, Research Triangle Park, NC.
325 Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
326 Product Information. Chirocaine (levobupivacaine) Organon, West Orange, NJ.
327 Heinonen J, Takki S, Jarho L "Plasma lidocaine levels in patients treated with potential inducers of microsomal enzymes." Acta Anaesthesiol Scand 14 (1970): 89-95. [PMID: 5428253]
328 Perucca E, Richens A "Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients." Br J Clin Pharmacol 8 (1979): 21-31. [PMID: 552293]
329 Perucca E, Ruprah M, Richens A, Park BK, Betteridge DJ, Hedges AM "Effect of low-dose phenobarbitone on five indirect indices of hepatic microsomal enzyme induction and plasma lipoproteins in normal subjects." Br J Clin Pharmacol 12 (1981): 592-6. [PMID: 6117310]
330 Reichel C, Skodra T, Nacke A, Spengler U, Sauerbruch T "The lignocaine metabolite (MEGX) liver function test and P-450 induction in humans." Br J Clin Pharmacol 46 (1998): 535-9. [PMID: 9862241]
331 Product Information. Myrbetriq (mirabegron). Astellas Pharma US, Inc, Deerfield, IL.
332 Miceli JJ, Anziano RJ, Robarge L, Hansen RA, Laurent A "The effect of carbamazepine on the steady-state pharmacokinetics of ziprasidone in healthy volunteers." Br J Clin Pharmacol 49(suppl 1) (2000): s65-70. [PMID: 10771457]
333 Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.